NCT04146896: A trial that was reported late by Aptinyx
This trial has reported, although it was 7 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04146896 |
|---|---|
| Title | A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 12, 2019 |
| Completion date | Feb. 23, 2022 |
| Required reporting date | Feb. 23, 2023, midnight |
| Actual reporting date | March 2, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 7 |